Retina

One in vitro study included in the manuscript was conducted in collaboration with researchers at the University of Southhampton in the United Kingdom

The investigators' findings suggest that CVI is a valuable noninvasive predictive biomarker for monitoring vascular changes in patients who smoke

The researchers reported a “notable” correlation which could serve as a predictive biomarker

The initiative marks the second annual ROP Awareness week, running from 24 February to 2 March, 2025

Researchers indicated that paediatric patients with Leber congenital amaurosis experienced improvements in vision

The biosimilar to aflibercept (Eylea) has already received approval in the EU and US

Francesco Bandello, MD, FEBO, discusses the Diabetic Eye Conditions Coalition and a five-point call to action

Risk factors vary in both short-term and long-term periods following Boston Type 1 keratoprosthesis surgery

The UK-based company will debut the tool, called Dr.Noon CVD, at two conferences in March

Professor Anat Loewenstein, MD, speaks about her presentation from the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting

The authors evaluated shallow irregular pigment epithelial detachment, subretinal hyperreflective material, subretinal fluid, intraretinal fluid and other baseline OCT biomarkers

Researchers screened for outcomes such as the presence of retinal diseases including age-related macular degeneration and retinal vein occlusion

The implant was tested in eyes of patients with bilateral age-related macular degeneration who underwent cataract surgery

Choroidal and retinal changes were examined with optical coherence tomography angiography

Previously, Susvimo was called the Port Delivery System with ranibizumab in the United States

OCU400 is the first gene therapy from the biotechnology company to move forward into Phase 3 with a broad retinitis pigmentosa (RP) indication

Pavblu and Skojoy, both from Amgen, are indicated for the treatment of neovascular age-related macular degeneration

The lead gene therapy candidate, AXV-101, is expected to enter clinical development in mid-2025

The gel addresses necrotic retinal cell death in dry age-related macular degeneration and geographic atrophy without requiring injections

The scientific outputs from MACUSTAR’s study could impact more than 200 million patients with AMD globally

Diana V. Do, MD, spoke on behalf of the HELIOS investigators at the Hawaiian Eye and Retina 2025 Meeting, in Kauai, HI

Ultrasounds reveal the distinct feature within the vitreous anterior, a promising diagnostic indicator for ocular pathologies

ARCATUS or ARVN001 was developed by Clearside Biomedical and commercialised in the Asia-Pacific region by Arctic Vision

Predictive software will use retinal imaging to identify patient risk for Alzheimer and other neurodegenerative diseases

The study findings suggest that patients should be educated about adherence to cold storage guidelines